WebMD’s Chief Medical Officer, John Whyte, MD, speaks with George Yancopoulos, MD, PhD, President & Chief Scientific Officer, Regeneron Pharmaceuticals Inc., about the development and promise of monoclonal antibody treatment.
Regeneron Co-Founder on Monoclonal Antibody Treatment
